Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Net Income (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Net Income data on record, last reported at -$17.4 million in Q4 2025.

  • For Q4 2025, Net Income fell 150.96% year-over-year to -$17.4 million; the TTM value through Dec 2025 reached -$72.7 million, changed N/A, while the annual FY2025 figure was -$72.7 million, N/A changed from the prior year.
  • Net Income reached -$17.4 million in Q4 2025 per PLSE's latest filing, up from -$19.3 million in the prior quarter.
  • Across five years, Net Income topped out at $34.2 million in Q4 2024 and bottomed at -$19.3 million in Q3 2025.
  • Average Net Income over 5 years is -$11.9 million, with a median of -$14.1 million recorded in 2021.
  • Peak YoY movement for Net Income: skyrocketed 386.6% in 2024, then plummeted 150.96% in 2025.
  • A 5-year view of Net Income shows it stood at -$15.4 million in 2021, then surged by 40.34% to -$9.2 million in 2022, then dropped by 29.75% to -$11.9 million in 2023, then skyrocketed by 386.6% to $34.2 million in 2024, then tumbled by 150.96% to -$17.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income were -$17.4 million in Q4 2025, -$19.3 million in Q3 2025, and -$19.2 million in Q2 2025.